Global BCG Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092406867

Publication Date:

September 11, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu茅rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG Vaccine market size was valued at US$ 408 million in 2023 and is forecast to a readjusted size of USD 590 million by 2030 with a CAGR of 5.5% during review period.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
This report is a detailed and comprehensive analysis for global BCG Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global BCG Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global BCG Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global BCG Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global BCG Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for BCG Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global BCG Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
BCG Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune BCG
Therapy BCG
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of BCG Vaccine, with price, sales quantity, revenue, and global market share of BCG Vaccine from 2019 to 2024.
Chapter 3, the BCG Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and BCG Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of BCG Vaccine.
Chapter 14 and 15, to describe BCG Vaccine sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global BCG Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immune BCG
1.3.3 Therapy BCG
1.4 Market Analysis by Application
1.4.1 Overview: Global BCG Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global BCG Vaccine Market Size & Forecast
1.5.1 Global BCG Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global BCG Vaccine Sales Quantity (2019-2030)
1.5.3 Global BCG Vaccine Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Vaccine Product and Services
2.1.4 Merck BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur BCG Vaccine Product and Services
2.2.4 Sanofi Pasteur BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab BCG Vaccine Product and Services
2.3.4 Japan BCG Lab BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Japan BCG Lab Recent Developments/Updates
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec BCG Vaccine Product and Services
2.4.4 China National Biotec BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Biotec Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Vaccine Product and Services
2.5.4 Serum Institute of India BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Intervax
2.6.1 Intervax Details
2.6.2 Intervax Major Business
2.6.3 Intervax BCG Vaccine Product and Services
2.6.4 Intervax BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intervax Recent Developments/Updates
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Vaccine Product and Services
2.7.4 GSBPL BCG Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSBPL Recent Developments/Updates
3 Competitive Environment: BCG Vaccine by Manufacturer
3.1 Global BCG Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global BCG Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global BCG Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of BCG Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 BCG Vaccine Manufacturer Market Share in 2023
3.4.3 Top 6 BCG Vaccine Manufacturer Market Share in 2023
3.5 BCG Vaccine Market: Overall Company Footprint Analysis
3.5.1 BCG Vaccine Market: Region Footprint
3.5.2 BCG Vaccine Market: Company Product Type Footprint
3.5.3 BCG Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global BCG Vaccine Market Size by Region
4.1.1 Global BCG Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global BCG Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global BCG Vaccine Average Price by Region (2019-2030)
4.2 North America BCG Vaccine Consumption Value (2019-2030)
4.3 Europe BCG Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific BCG Vaccine Consumption Value (2019-2030)
4.5 South America BCG Vaccine Consumption Value (2019-2030)
4.6 Middle East & Africa BCG Vaccine Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global BCG Vaccine Sales Quantity by Type (2019-2030)
5.2 Global BCG Vaccine Consumption Value by Type (2019-2030)
5.3 Global BCG Vaccine Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global BCG Vaccine Sales Quantity by Application (2019-2030)
6.2 Global BCG Vaccine Consumption Value by Application (2019-2030)
6.3 Global BCG Vaccine Average Price by Application (2019-2030)
7 North America
7.1 North America BCG Vaccine Sales Quantity by Type (2019-2030)
7.2 North America BCG Vaccine Sales Quantity by Application (2019-2030)
7.3 North America BCG Vaccine Market Size by Country
7.3.1 North America BCG Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America BCG Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe BCG Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe BCG Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe BCG Vaccine Market Size by Country
8.3.1 Europe BCG Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe BCG Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific BCG Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific BCG Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific BCG Vaccine Market Size by Region
9.3.1 Asia-Pacific BCG Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific BCG Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America BCG Vaccine Sales Quantity by Type (2019-2030)
10.2 South America BCG Vaccine Sales Quantity by Application (2019-2030)
10.3 South America BCG Vaccine Market Size by Country
10.3.1 South America BCG Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America BCG Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa BCG Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa BCG Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa BCG Vaccine Market Size by Country
11.3.1 Middle East & Africa BCG Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa BCG Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 BCG Vaccine Market Drivers
12.2 BCG Vaccine Market Restraints
12.3 BCG Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of BCG Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of BCG Vaccine
13.3 BCG Vaccine Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 BCG Vaccine Typical Distributors
14.3 BCG Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂